Azetidine derivative

US11014943B2 · kind B2 · utility

Assignee

• Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · CN

Inventors

• Jian Xiong · Shanghai, CN
• Cheng Xie · Shanghai, CN
• Kevin X. Chen · Edison, US
• Xiongbin XU · Shanghai, CN
• Xuejin Zhang · 安丰镇, CN
• Zhen Gong · Shanghai, CN
• Jian Li · Shanghai, CN
• Shuhui CHEN · Shanghai, CN
• Aiming Zhang · Lianyungang, CN
• Zhulian JIANG · Lianyungang, CN
• Xiquan Zhang · 安丰镇, CN
• Xin Tian · 安丰镇, CN

Key dates

• Filing date: Feb 28, 2018
• Grant date: May 25, 2021
• Expiry date: May 21, 2038

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07F5/02
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Disclosed in the present application are a compound represented by formula (I), or a pharmaceutically acceptable salt, a tautomer thereof, a stereoisomer thereof, or a geometrical isomer thereof, and uses thereof in the preparation of drugs for treating or preventing multiple myeloma.